A detailed history of Nuveen Asset Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,222,895 shares of BMRN stock, worth $81.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,222,895
Previous 1,061,602 15.19%
Holding current value
$81.5 Million
Previous $87.4 Million 1.65%
% of portfolio
0.02%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$69.02 - $93.84 $11.1 Million - $15.1 Million
161,293 Added 15.19%
1,222,895 $86 Million
Q2 2024

Aug 09, 2024

BUY
$74.43 - $92.22 $15.4 Million - $19.1 Million
207,210 Added 24.25%
1,061,602 $87.4 Million
Q1 2024

May 13, 2024

BUY
$83.81 - $99.0 $20.4 Million - $24.1 Million
242,978 Added 39.74%
854,392 $74.6 Million
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $2.66 Million - $3.44 Million
34,905 Added 6.05%
611,414 $59 Million
Q3 2023

Nov 14, 2023

SELL
$85.07 - $94.48 $1.25 Million - $1.39 Million
-14,708 Reduced 2.49%
576,509 $51 Million
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $426,638 - $493,676
4,922 Added 0.84%
591,217 $51.2 Million
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $2.71 Million - $3.62 Million
30,890 Added 5.56%
586,295 $57 Million
Q4 2022

Feb 14, 2023

SELL
$80.93 - $108.63 $6.71 Million - $9 Million
-82,857 Reduced 12.98%
555,405 $57.5 Million
Q3 2022

Nov 14, 2022

SELL
$82.16 - $96.94 $394,943 - $465,990
-4,807 Reduced 0.75%
638,262 $54.1 Million
Q2 2022

Aug 15, 2022

SELL
$71.48 - $86.85 $2.21 Million - $2.68 Million
-30,907 Reduced 4.59%
643,069 $53.3 Million
Q1 2022

May 16, 2022

SELL
$74.28 - $92.69 $9.19 Million - $11.5 Million
-123,756 Reduced 15.51%
673,976 $54.7 Million
Q4 2021

Feb 14, 2022

SELL
$71.72 - $91.47 $1.11 Million - $1.41 Million
-15,422 Reduced 1.9%
797,732 $70.5 Million
Q3 2021

Nov 12, 2021

SELL
$74.77 - $85.47 $12.7 Million - $14.5 Million
-169,862 Reduced 17.28%
813,154 $62.8 Million
Q2 2021

Aug 16, 2021

SELL
$75.51 - $84.79 $33.3 Million - $37.4 Million
-440,648 Reduced 30.95%
983,016 $82 Million
Q1 2021

May 17, 2021

SELL
$74.73 - $90.69 $4.51 Million - $5.47 Million
-60,324 Reduced 4.06%
1,423,664 $108 Million
Q4 2020

May 17, 2021

SELL
$72.61 - $90.2 $257,547 - $319,939
-3,547 Reduced 0.24%
1,483,988 $130 Million
Q4 2020

Feb 16, 2021

SELL
$72.61 - $90.2 $38.4 Million - $47.7 Million
-528,782 Reduced 26.23%
1,487,535 $130 Million
Q3 2020

Nov 16, 2020

SELL
$71.87 - $131.03 $77.1 Million - $141 Million
-1,072,692 Reduced 34.73%
2,016,317 $153 Million
Q2 2020

Aug 14, 2020

BUY
$79.55 - $124.22 $101 Million - $158 Million
1,269,435 Added 69.77%
3,089,009 $381 Million
Q1 2020

May 14, 2020

BUY
$71.37 - $96.85 $68.6 Million - $93.1 Million
961,494 Added 112.05%
1,819,574 $154 Million
Q4 2019

Feb 14, 2020

SELL
$64.27 - $86.37 $27.1 Million - $36.4 Million
-421,396 Reduced 32.94%
858,080 $72.6 Million
Q3 2019

Nov 14, 2019

SELL
$67.4 - $85.11 $117 Million - $148 Million
-1,733,420 Reduced 57.53%
1,279,476 $86.2 Million
Q2 2019

Aug 15, 2019

BUY
$80.35 - $93.9 $242 Million - $283 Million
3,012,896 New
3,012,896 $258 Million
Q2 2018

Aug 14, 2018

SELL
$76.01 - $99.03 $270,139 - $351,952
-3,554 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$77.67 - $92.63 $32,310 - $38,534
-416 Reduced 10.48%
3,554 $288,000
Q4 2017

Feb 14, 2018

BUY
$80.76 - $95.13 $320,617 - $377,666
3,970
3,970 $0

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.